The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
Toll-like receptors (TLR) play a dual regulatory role in the tumor microenvironment (TME). TLR agonists (TLRa) elicit both innate and adaptive immune responses to achieve anti-tumor effects, whereas the inflammatory response induced by TLRa contributes to the immune escape of tumor cells. Preliminar...
Saved in:
Main Authors: | Xue Chen (Author), Yunxiao Zhang (Author), Yao Fu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
by: Lingling Huang, et al.
Published: (2022) -
Profiling of Toll-like Receptors and Related Signaling Mediators in the Pathogenesis of Morphea
by: Hilal Ayvaz Celik, et al.
Published: (2024) -
The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure
by: Lili Yu, et al.
Published: (2018) -
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
by: Hao Sun, et al.
Published: (2022) -
Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists
by: Sehwan Jeong, et al.
Published: (2021)